Steven Gannon - Net Worth and Insider Trading

Steven Gannon Net Worth

The estimated net worth of Steven Gannon is at least $1 Million dollars as of 2024-11-10. Steven Gannon is the Director of Fusion Pharmaceuticals Inc and owns about 56,400 shares of Fusion Pharmaceuticals Inc (FUSN) stock worth over $1 Million. Steven Gannon is also the Director of Xenon Pharmaceuticals Inc and owns about 2,000 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $90,000. Details can be seen in Steven Gannon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven Gannon has not made any transactions after 2024-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Steven Gannon

To

Steven Gannon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven Gannon owns 2 companies in total, including Fusion Pharmaceuticals Inc (FUSN) , and Xenon Pharmaceuticals Inc (XENE) .

Click here to see the complete history of Steven Gannon’s form 4 insider trades.

Insider Ownership Summary of Steven Gannon

Ticker Comapny Transaction Date Type of Owner
FUSN Fusion Pharmaceuticals Inc 2022-08-11 director
XENE Xenon Pharmaceuticals Inc 2024-03-07 director

Steven Gannon Latest Holdings Summary

Steven Gannon currently owns a total of 2 stocks. Among these stocks, Steven Gannon owns 56,400 shares of Fusion Pharmaceuticals Inc (FUSN) as of August 11, 2022, with a value of $1 Million and a weighting of 93.11%. Steven Gannon also owns 2,000 shares of Xenon Pharmaceuticals Inc (XENE) as of March 7, 2024, with a value of $90,000 and a weighting of 6.89%.

Latest Holdings of Steven Gannon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FUSN Fusion Pharmaceuticals Inc 2022-08-11 56,400 21.55 1,215,420
XENE Xenon Pharmaceuticals Inc 2024-03-07 2,000 45.00 90,000

Holding Weightings of Steven Gannon


Steven Gannon Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven Gannon has made a total of 4 transactions in Fusion Pharmaceuticals Inc (FUSN) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Fusion Pharmaceuticals Inc is the acquisition of 44,400 shares on August 11, 2022, which cost Steven Gannon around $90,132.

According to the SEC Form 4 filings, Steven Gannon has made a total of 1 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 13,000 shares on March 7, 2024, which brought Steven Gannon around $601,640.

Insider Trading History of Steven Gannon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven Gannon Trading Performance

GuruFocus tracks the stock performance after each of Steven Gannon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven Gannon is -13.48%. GuruFocus also compares Steven Gannon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven Gannon within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steven Gannon's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steven Gannon

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.68 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.97 LIMIT LIMIT LIMIT LIMIT LIMIT

Steven Gannon Ownership Network

Ownership Network List of Steven Gannon

No Data

Ownership Network Relation of Steven Gannon

Insider Network Chart

Steven Gannon Owned Company Details

What does Fusion Pharmaceuticals Inc do?

Who are the key executives at Fusion Pharmaceuticals Inc?

Steven Gannon is the director of Fusion Pharmaceuticals Inc. Other key executives at Fusion Pharmaceuticals Inc include Chief Medical Officer Dmitri Bobilev , director & Chief Executive Officer John Valliant , and Chief Scientific Officer Christopher P Leamon .

Fusion Pharmaceuticals Inc (FUSN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Fusion Pharmaceuticals Inc (FUSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fusion Pharmaceuticals Inc (FUSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Fusion Pharmaceuticals Inc (FUSN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Fusion Pharmaceuticals Inc Insider Transactions

No Available Data

Steven Gannon Mailing Address

Above is the net worth, insider trading, and ownership report for Steven Gannon. You might contact Steven Gannon via mailing address: C/o Xenon Pharmaceuticals Inc., 200 - 3650 Gilmore Way, Burnaby A0 V5g 4w8.